|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Jan―17 |
Impact of COVID-19 on gut-lung microbiota a mini review |
Reza Emadi, Parastoo Yousefi, Alireza Tabibzadeh |
2 |
[GO] |
2025―Jan―08 |
Are we ready for the next pandemic: Disease X |
Ali Kemal Erenler, Behice Hande Erenler, Ahmet Baydin |
3 |
[GO] |
2025―Jan―03 |
Antibody responses after COVID-19 vaccination: a cross sectional study among the Bangladeshi population |
Moumita Das, A.F.M. Tareq Bhuiyan, Md. Hasanul Karim, Md. Amzad Hossain, Md. Abdur Rob, Shamim Khan, et al. (+8) Jannatun Wnaiza, Rony Chandra Shil, Mohabbat Hossain, Nahidur Rahman, Farjana Sharmen, Afroza Akter Tanni, S.M. Rafiqul Islam, Adnan Mannan |
4 |
[GO] |
2024―Nov―14 |
Knowledge, perception, and attitudes regarding the new COVID-19 delta variant pandemic among medical health workers and patients at the National Center of Hematology |
Huda Ibraheem Abd AL-Lateef, Shahla’a Fadhil Sabir, Mayadah Mohammed Ridha |
5 |
[GO] |
2024―Nov―14 |
COVID-19 omicron variant: variation from other variants, immune response, and vaccination against this rapidly spreading pandemic |
Yasmen Mahmoud, Amira Hathout, Radwa Abdallnasser Amen, Sara Desouky, Rawan Muhammad Shady, Heba Mohamed Fahmy |
6 |
[GO] |
2024―Nov―14 |
A review of SARS-CoV-2 virology, vaccines, variants and their impact on the COVID-19 pandemic |
Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, Shahan ul Quraish |
7 |
[GO] |
2024―Nov―14 |
Procalcitonin, C-reactive protein, ferritin and interleukin-37 levels among COVID-19 patients in the presence or absence of secondary bacterial infections |
Aliaa Jabbar Qasim, Eman Natiq Naji, Suad Almas Brakhas |
8 |
[GO] |
2024―Nov―14 |
Airway management in patients with COVID-19: an updated guide for clinicians in the emergency department |
Ali Kemal Erenler, Seval Komut, Mustafa Çapraz, Ahmet Baydin |
9 |
[GO] |
2024―Nov―14 |
Severe acute respiratory syndrome coronavirus 2 and Legionella co-infection in a child with sleep disorder: a case report |
Shirin Dashtbin, Saba Jalalifar, Gholamreza Bayazian, Gholamreza Irajian, Alireza Nateghian |
10 |
[GO] |
2024―Nov―14 |
Vitamin D and immune response against severe acute respiratory syndrome coronavirus 2 in older adults: does it really work? |
Adriana B. Pedreáñez, Jesús A. Mosquera-Sulbarán, Nelson E. Muñáz, Diego M. Tene, Jorge G. Robalino |
11 |
[GO] |
2024―Nov―14 |
Severe acute respiratory syndrome coronavirus 2 pandemic and older people: what we know about the clinical, laboratory, imaging features, and clinical outcomes |
Shereen Abdel Alem, Ahmed Moustafa |
12 |
[GO] |
2024―Nov―14 |
Thromboembolism: the secret lethal weapon of coronavirus disease 2019 |
Abdulrahman K. Ahmed, Eslam R. Moustafa, Aya M. Abd EL-Monem, Galal A. Hasan, Omar A. Mohamed, Islam H. Ibrahim, et al. (+4) Gaber El-Saber Batiha, Israa M.S. Al-Kadmy, Amal Hosni, Helal F. Hetta |
13 |
[GO] |
2024―Nov―14 |
Single nucleotide polymorphism in toll-like receptor 3 gene as a potential risk factor for severe outcome of coronavirus disease 2019 |
Mehdi Ramshini, Farah Bokharaei-Salim, Tahereh Donyavi, Majid Khoshmirsafa, Saied Ghorbani, Alireza Khatami, et al. (+8) Mohammad Abbasi-Kolli, Alireza Safi Deh Naeini, Ensieh Jafari, Ahmad Tavakoli, Seyed Hamidreza Monavari, Anjila Ataei-Pirkooh, Zohreh Yousefi Ghalejoogh, Seyed Jalal Kiani |
14 |
[GO] |
2024―Nov―14 |
Applications of nanotechnology in the fight against coronavirus disease 2019 |
Reem Sayad, Huda Ahmed Abdelsabour, Samia Mohamed Farhat, Nehal Gamal Omer, Manar Magdy Ahmed, Ibrahim Khalid Elsayh, et al. (+5) Islam H. Ibrahim, Abdelazeem M. Algammal, Israa M.S. AL-Kadmy, Gaber El-Saber Batiha, Helal F. Hetta |
15 |
[GO] |
2024―Nov―14 |
Knowledge, attitude and practice towards coronavirus disease 2019 among Indian residents - an online cross-sectional survey |
Kalaivani Manokaran, Saritha Kamath U., Aneena Varghese, Ravi Shankar N., Siddharth Kaushik, Shiek Fareeth Ahmed, et al. (+3) Robert Selvam, Prabu Paramasivam, Anju M. |
16 |
[GO] |
2024―Nov―14 |
Diagnostic performance of two commercially available coronavirus disease 2019 antibody kits: Elecsys Anti-SARS CoV-2 (Roche) and Anti-SARS-CoV-2 ELISA (IgG) (Euroimmun) |
Abdurrahman Sarmis, Mucahide Esra Kocoglu, Hasan Guclu, Zafer Habip, Tuncer Ozekinci |
17 |
[GO] |
2022―Mai―25 |
Intravenous immunoglobulin and treatment in COVID-19 patients: case series |
Negar Mohtadi, Abas Ghaysouri, Ali Nazari, Jalil Feizi, Hamed Tavan |
18 |
[GO] |
2022―Jan―20 |
The effectiveness of the immune responses to SARS-CoV-2 |
Barik A. Salih |
19 |
[GO] |
2021―Jun―06 |
Coronavirus disease 2019 |
Yeruva Thirupathaiah, Anuj Kumar Chandel |
20 |
[GO] |
2021―Apr―19 |
Assessment of different laboratory tests for the diagnosis of novel coronavirus infections |
Rozita Ghojoghi, Bahareh Zamani, Abbas Behzad Behbahani |
21 |
[GO] |
2021―Feb―21 |
Frequency of underlying diseases, symptoms and mortality rate of COVID-19 |
Morteza Shams, Gholam Basati, Gholamreza Kalvandi, Amir Abdoli, Hamed Tavan |
22 |
[GO] |
2021―Jan―20 |
Severe acute respiratory syndrome coronavirus 2 infection in an Iranian HIV-positive patient |
Rahim Raoofi, Mohammad Aref Bagherzadeh, Ahmadreza Bazmjoo, Heshmatollah Shakeri, Alireza Abbasi, Amir Abdoli |
23 |
[GO] |
2021―Jan―20 |
The coronavirus disease 2019 and effect on liver function |
Parastoo Hosseini, Shervin Afzali, Mohammadreza Karimi, Milad Zandi, Arghavan Zebardast, Tayebe Latifi, et al. (+7) Alireza Tabibzadeh, Akam Ramezani, Armin Zakeri, Amirmohammad Zakeri, Behnam Abedi, Saber Soltani, Abbas Farahani |
24 |
[GO] |
2021―Jan―15 |
Genetic and structure of novel coronavirus COVID-19 and molecular mechanisms in the pathogenicity of coronaviruses |
Bahman Yousefi, Majid Eslami |
25 |
[GO] |
2021―Jan―15 |
Micronutrient zinc roles in adjunctive therapy for COVID-19 by enhancing patients immunoregulation and tolerance to the pathogen |
Ba Xuan Hoang, Bo Han |
26 |
[GO] |
2020―Dez―05 |
Current drugs with potential for coronavirus disease 2019 therapy |
Samin Alihosseini, Hamed Ebrahimzadeh Leylabadlo, Mahdi Parsaei, Nazila Sarafraz, Khudaverdi Ghanbarov, Silvano Esposito, Hossein S. Kafil |
27 |
[GO] |
2020―Sep―01 |
Pathophysiology of COVID-19 infection |
Mohammadreza Hashemi Aghdam, Ramin Hosseinzadeh, Behzad Motallebizadeh, Mohammadreza Rezaeimehr, Leila Khedmat, Zahra Soleimani, et al. (+4) Mohammad Heiat, Mehrdad Moosazadeh Moghaddam, Mohammadali Abyazi, Ashraf Karbasi |
28 |
[GO] |
2020―Sep―01 |
A review on an ongoing pandemic caused by the severe acute respiratory syndrome coronavirus 2 |
Solmaz Ohadian Moghadam |
29 |
[GO] |
2020―Sep―01 |
SARS-CoV-2 receptor ACE2 and molecular pathway to enter target cells during infection |
Khadijeh Najafi, Parham Maroufi, Ehsaneh Khodadadi, Elham Zeinalzadeh, Khudaverdi Ganbarov, Mohammad Asgharzadeh, Hossein Samadi Kafil |
30 |
[GO] |
2020―Aug―08 |
Cytokine storm is the cryptic killer behind coronavirus disease-2019 infections, review of the current evidence to identify therapeutic options |
Diaa Alrahmany, Islam M. Ghazi |
31 |
[GO] |
2020―Jul―16 |
An overview on wearing the face mask to avoid transmission of coronavirus disease 2019 |
Maryam Mohammadbeigi, Maryam Meskini, Safarali Alizadeh Koshkohi |
32 |
[GO] |
2020―Jun―23 |
What is the novel coronavirus disease 2019 (COVID-19) that paralyze the world? |
Ali Ozturk, Olkar Abdulmajed, Bashar Ibrahim |